Back
Legend Biotech Corp. 10K Form
Sell
4
LEGN
Legend Biotech Corp.
Last Price:
$22.19
Seasonality Move:
-11.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LEGN News And Ratings
See the #1 stock for the next 7 days that we like better than LEGN
LEGN Financial Statistics
Sales & Book Value
| Annual Sales: | $627.6M |
|---|---|
| Cash Flow: | $15.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.48 |
| Price / Book: | 4.07 |
Profitability
| EPS (TTM): | -1.30510 |
|---|---|
| Net Income (TTM): | $-240.3M |
| Gross Margin: | $369.5M |
| Return on Equity: | -23.01% |
| Return on Assets: | -14.26% |
Legend Biotech Corp. Earnings Forecast
Key Legend Biotech Corp. Financial Ratios
-
The Gross Profit Margin over the past 8 years for LEGN is 58.88%.
-
The Selling, General & Administrative Expenses for LEGN have been equal to 45.32% of Gross Profit Margin.
-
The Research & Development expenses have been 65.93% of Revenue.
-
The Net Earning history of LEGN is -28.22% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
Legend Biotech Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LEGN |
| CUSIP: | 52490G |
| Website: | legendbiotech.com |
Debt
| Debt-to-Equity Ratio: | 0.41 |
|---|---|
| Current Ratio: | 2.86 |
| Quick Ratio: | 2.29 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 32.59 |
LEGN Technical Analysis vs Fundamental Analysis
Sell
4
Legend Biotech Corp. (LEGN)
is a Sell
Is Legend Biotech Corp. a Buy or a Sell?
-
Legend Biotech Corp. stock is rated a SellThe current Legend Biotech Corp. [LEGN] share price is $22.32. The Score for LEGN is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.